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Wallerian degeneration refers to a loss of the distal part of an axon after nerve injury. Wallerian degeneration slow
(Wld
s) mice overexpress a chimeric protein containing the NAD synthase NMNAT (nicotinamide mononucleotide
adenylyltransferase 1) and exhibit a delay in axonal degeneration. Currently, conflicting evidence raises questions as
to whether NMNAT is the protecting factor and whether its enzymatic activity is required for such a possible function.
Importantly, the link between nmnat and axon degeneration is at present solely based on overexpression studies of
enzymatically active protein. Here we use the visual system of Drosophila as a model system to address these issues.
We have isolated the first nmnat mutations in a multicellular organism in a forward genetic screen for synapse
malfunction in Drosophila. Loss of nmnat causes a rapid and severe neurodegeneration that can be attenuated by
blocking neuronal activity. Furthermore, in vivo neuronal expression of mutated nmnat shows that enzymatically
inactive NMNAT protein retains strong neuroprotective effects and rescues the degeneration phenotype caused by loss
of nmnat. Our data indicate an NAD-independent requirement of NMNAT for maintaining neuronal integrity that can
be exploited to protect neurons from neuronal activity-induced degeneration by overexpression of the protein.
Citation: Zhai RG, Cao Y, Hiesinger PR, Zhou Y, Mehta SQ, et al. (2006) Drosophila NMNAT maintains neural integrity independent of its NAD synthesis activity. PLoS Biol 4(12):
e416. DOI: 10.1371/journal.pbio.0040416
Introduction
Following nerve injury, distal axons and synaptic terminals
undergo Wallerian degeneration within 48 h [1]. This process
occurs in both the central and peripheral nervous systems
and has several key features: (1) the distal stump of an injured
axon loses its ability to transmit action potentials; (2) the
axon and synaptic terminal become fragmented; (3) the
cytoskeleton undergoes granular degeneration; and (4) the
axonal and nerve terminal debris are removed by Schwann
cells and invading macrophages [2]. Recent studies have
started to unveil the molecular mechanisms of Wallerian
degeneration. Inhibiting ubiquitination delays axon degen-
eration, suggesting the involvement of ubiquitin-mediated
proteasomal degradation in the early stages of Wallerian
degeneration [3]. In addition, studies have suggested that
Wallerian degeneration is distinct from the apoptosis path-
way, because caspases are not involved in Wallerian degen-
eration, and overexpression of apoptosis-inhibiting factors
and mutations that block apoptosis fail to prevent axonal
degeneration [4–6].
The discovery of the slow Wallerian degeneration mutant
(Wld
s) mouse, in which Wallerian degeneration is delayed by
2–3 wk, has provided a genetic inroad to study the
mechanisms of deterioration and protection in axonal
degeneration [7–10]. The pronounced delay in degeneration
is caused by a tandem triplication of an 85-kilobase (kb)
region, resulting in the overexpression of a chimeric Ube4b/
Nmnat gene, which contains the amino terminal 70–amino
acid fragment of Ube4b (ubiquitination factor E4B), the entire
coding sequence of Nmnat1, and a unique 18–amino acid
linking region translated from the 59 untranslated region
(UTR) of Nmnat1 [11,12]. Overexpression of the fusion
protein in transgenic mice and rats reproduces the Wld
S
phenotype [12,13], and recent studies show that overexpres-
sion of this fusion protein in Drosophila also protects axons
from degeneration [14]. However, there are conﬂicting
reports as to whether Nmnat1 alone is the protective factor
[15–18], because transgenic mice overexpressing Nmnat1 do
not exhibit protection from Wallerian degeneration [15,16].
In contrast, a detailed analysis of Wld
s chimeric protein in the
central nervous system (CNS) suggests that the increased level
of Nmnat1 is signiﬁcant in Wld
s mice and that there is no
obvious change in ubiquitination. Hence, its protective
effects seem to be unrelated to the ubiquitination function
of Ube4b [17]. In Drosophila, overexpression of nmnat can
delay axonal degeneration [18]. The role of Ube4b remains
controversial, however, as transfection of N70-Ube4b in
cultured neurons does not produce a protective phenotype
[19]. On the other hand, a recent report indicates that N70-
Ube4b binds an important proteasomal chaperone (VCP) and
relocates it to the nucleus [20]. Hence, it remains to be
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PLoS BIOLOGYestablished whether N70-Ube4b is sufﬁcient and/or necessary
for a protective phenotype.
Two in vitro studies pinpoint Nmnat1 as the protective
agent and suggest that it acts either in the nucleus [19] or
locally in axons [21]. Although both in vitro studies indicate a
requirement of NAD for the protective effect, Wld
s mice do
not exhibit increased NAD levels [12]. This ﬁnding suggests
either that local ﬂuctuation of NAD levels is under the
detection limit or that the Nmnat1 protein may have
additional functions beyond NAD synthesis.
Understanding the normal neuronal function of endoge-
nous Nmnat in vivo is crucial to unveiling the mechanisms of
neural degeneration and neural protection offered by Wld
s
protein. Here we show that loss of Drosophila nmnat causes
severe neuronal and synaptic degeneration without affecting
neural development. Importantly, this nmnat-dependent
degeneration in photoreceptors can be attenuated by block-
Figure 1. Mutations in Complementation Group 3R4 Disrupt Synaptic Structures in Photoreceptor Terminals
(A–F) External morphology of the homozygous eyes of 3R4
1 (C) and 3R4
2 (E) are normal when compared to those of isogenized control (A). Red eye
color marks heterozygous patches. (B), (D), and (F) ERG recordings of control and mutant eyes. Note the reduced depolarization and on/off response.
Bar above trace in (B) indicates duration of light stimulus.
(G–I) TEM micrographs of lamina cartridges containing control, 3R4
1, and 3R4
2 mutant terminals, respectively. Demarcating glia are colored blue and
photoreceptor terminals green to accentuate the structures. Note the photoreceptor terminals are disorganized in mutants. The yellow boxes in (G) and
(I) indicate the regions shown in (J) and (K), respectively. The red boxes in (G) and (H) indicate the regions shown in (L) and (M), respectively. Scale bar in
(G) for (G–I) indicates 1 lm.
(J) and (K) Individual terminals that are boxed in (G) and (I) (yellow boxes). nmnat mutant terminals have amorphic active zone structures (red arrows),
aberrant capitate projections (blue arrows), aberrant mitochondria (yellow arrowheads), and abnormal membranes (yellow arrow), as well as an
aberrant cytoskeleton (blue arrowheads), which are not observed in wild-type terminals. Scale bar indicates 200 nm.
(L) and (M) Individual active zones that are boxed in (G) and (H) (red boxes). Compared to the clearly defined wild-type active zone structure (L), nmnat
mutant active zones are amorphic and reduced in size. Both wild-type and mutant T-bars are surrounded by synaptic vesicles. Scale bar indicates 200
nm.
(N) and (O) Quantification of synapse number and size. No significant difference was found in the average number of active zones per terminal between
control (118 terminals counted), and 3R4
1 (93 terminals counted) or 3R4
2 (71 terminals counted). Synapse size was measured by the width of T-bar
platform profile (L) (insert). The size of T-bars in either 3R4
1 (23 measured) or 3R4
2 (31 measured) is significantly reduced compared to the control (38
measured). An asterisk (*) indicates p , 0.05.
DOI: 10.1371/journal.pbio.0040416.g001
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NMNAT Maintains Neuronal Inegritying phototransduction. NMNAT therefore functions to
protect against activity-induced deterioration under normal
conditions, and overexpression of NMNAT protects neurons
from excessive activity-induced degeneration. This role is
independent of its NAD synthesis activity, because over-
expression of NMNAT protein with less than 1% activity can
rescue the degeneration caused by loss of nmnat and has
strong protective effects. We conclude that NMNAT is
required to maintain neuronal integrity independent of its
NAD synthesis function.
Results
Drosophila nmnat Is a Homolog of Mouse Nmnat1
Overexpressed in Wld
s
To identify genes that are involved in synapse development
and function, we carried out a forward genetic screen using
the eyFLP system [22–24]. The eyFLP system allows screening
of ﬂies that are homozygous for lethal mutations in the visual
system but heterozygous in the rest of the animal [25]. Our
primary screen was based on isolating ethyl methanesulfonate
(EMS)-induced mutants that fail in a phototaxis assay,
followed by screening for defects in electroretinograms
(ERGs) and assessing morphological defects of photoreceptor
axons and terminals [22]. We screened 210,000 ﬂies and
isolated 7,500 ﬂies with grossly normal eye morphology that
phototax poorly [26]. We next subjected the ﬂies to ERG tests
and isolated 450 mutants with abnormal ERG responses.
Subsequent complementation tests yielded 64 complementa-
tion groups with two or more alleles.
The Drosophila compound eye consists of 800 unit eyes, or
ommatidia, each of which contains eight photoreceptors.
Photoreceptors 1–6 (R1–R6) project to the ﬁrst optic neuro-
pil, or lamina, whereas R7 and R8 project deeper into the
Figure 2. Complementation Group 3R4 Encodes nmnat, an Adenylyltransferase
(A) Fine mapping using the P element recombination method. The insertion sites of the five P elements used to map the gene are marked by red
arrows. The recombination ratio for each P element is listed in centiMorgans (cM). The red box marks the region delineated by fine mapping.
(B) The genomic region of CG13645. The point mutations uncovered by sequencing are marked by red arrowheads. The genomic rescue construct and
the cDNA rescue construct are both marked in green. The blue arrow indicates the insertion site of P element EY4790 used to generate the excision
lines D4790–1 and -2. The boundaries of the excised regions are marked by brackets in the blue lines.
(C) Drosophila NMNAT protein is homologous to mouse and human NMNAT1,  2, and  3. Percentages of similarity and identity to each mouse and
human protein are listed.
(D) The organization of the NMN adenylyltransferase activity center. The key amino acids mutated to reduce enzymatic activity are marked by asterisks
(*). The amino acid positions of the nonsense mutations in both alleles are marked by red arrowheads.
(E) The Drosophila NMNAT protein has similar enzymatic activity as human NMNAT3. The activity is measured by the continuous coupling assay and
listed in units per milligram of recombinant protein. The mutant proteins H30A, W98G, R224A, and WR (W98G/R224A double mutant) have 1.4%, 22%,
10.8%, and 0.9% of the activity of wild-type protein, respectively.
DOI: 10.1371/journal.pbio.0040416.g002
PLoS Biology | www.plosbiology.org December 2006 | Volume 4 | Issue 12 | e416 2338
NMNAT Maintains Neuronal Inegritybrain [27]. To isolate genes that speciﬁcally regulate synapse
assembly and maintenance, we carried out a systematic
transmission electron microscopy (TEM) analysis to uncover
mutants with abnormal synapse structure in R1–R6 terminals
[28]. Out of 60 mutants analyzed by TEM, two homozygous
lethal mutations with abnormal active zone morphology that
fail to complement each other (3R4
1 and 3R4
2) were isolated.
As shown in Figure 1A, 1C, and 1E, eyes that are mostly
homozygous mutant (white areas) for either of the two alleles
of complementation group 3R4 are smooth and have a
normal external morphology, suggesting that eye develop-
ment is normal. ERGs, extracellular recordings that measure
the response of photoreceptor neurons to a light stimulus,
were performed on animals with eyes mutant for either allele.
3R4 mutants exhibit a reduced depolarization and reduced
on/off response in young animals (Figure 1B, 1D, and 1F),
suggesting that the mutant photoreceptors have an impaired
ability to respond to light and to elicit a postsynaptic
response. We next examined the ultrastructure of lamina
synapses where the ERG response is generated. As shown in
Figure 1G–1I, TEM of lamina synapses of 1-d-old ﬂies reveals
morphological defects. In contrast to the organized cartridge
structure in control lamina with six photoreceptor terminals
per cartridge (Figure 1G), the mutant laminae are disorgan-
ized, with various number of terminals (Figure 1H and 1I).
Within the terminals, we observe a fragmented cytoskeleton
and misshapen membrane organelles (Figure 1K). More
interestingly, the mutant synaptic structure exhibits distinct
phenotypes. In Drosophila presynaptic terminals, active zones
have synaptic ribbon structures called T-bars that each
consist of a ‘‘platform’’ and a ‘‘pedestal’’ [29]. In 3R4 mutants,
T-bars are amorphous and less electron dense compared to
wild type, but they are surrounded by clusters of normally
sized synaptic vesicles (Figure 1K and 1M). Although the
number of synapses per terminal is not altered, the size of the
T-bar proﬁle, measured by the width of platforms (Figure 1L,
insert), is signiﬁcantly reduced compared to the control
(Figure 1N and 1O).
To identify the molecular lesions of the two alleles of 3R4,
we mapped the lethality associated with this complementa-
tion group using P element mapping [30]. Fine mapping with
ﬁve P elements pinpointed a 50-kb region at cytological
location 96B11 (Figure 2A). Sequencing of 25 kb of genomic
DNA showed that both alleles have nonsense mutations in
gene CG13645 (Figure 2B). Expression of the cDNA (green) in
photoreceptors rescues both the ERG phenotype and the
morphology of synaptic terminals (Figure S1, Table S1).
Moreover, a genomic transgene containing the CG13645 locus
(Figure 2B; green) fully rescues the lethality, the ERG defects,
and the synaptic defects (Figure S1A–S1D). These data show
that CG13645 corresponds to the gene that is mutated in the
3R4 alleles and that its loss or partial loss causes the observed
defects.
The nonsense mutations in both alleles map to the C-
terminal half of the predicted protein (Figure 2B), and it is
therefore possible that truncated proteins are produced that
have residual function. To create null mutations of CG13645,
we imprecisely excised a P element (EY4790) [31] inserted 50
nt upstream of the ﬁrst exon. Two alleles, D4790–1 and
D4790–2, were generated that cause deletions of the ﬁrst
three or four exons (Figure 2B; blue). These alleles fail to
complement the lethality associated with the two EMS-
induced alleles, have the same lethal phase (ﬁrst instar larval
stage), display the same ERG defects, and exhibit the same
photoreceptor synaptic defects in TEM as the EMS alleles
(unpublished data). These data indicate that both EMS-
induced alleles are functional null alleles.
CG13645 encodes NMNAT, a nicotinamide mononucleo-
tide adenylyltransferase, which is a conserved, essential
enzyme in most organisms. In humans, three isoforms,
NMNAT1, 2, and 3, have been cloned, and their enzymatic
properties have been analyzed [32–35]. There are also three
Figure 3. NMNAT Is Highly Enriched in the Nervous System and the
Muscle Nuclei
(A–C) Third instar larval neuromuscular junction (NMJ) immunolabeled
for HRP (red), with nc82 to mark the active zones (green), and for NMNAT
(blue). In the NMJ, NMNAT appears as punctae that co-localize with nc82.
NMNAT is also enriched in the muscle nucleus (marked by N in [A]).
(D–F) Optic lobe (Pþ60%) immunolabeled for Synaptotagmin (syt) to
mark synaptic vesicles (blue), with nc82 to mark active zones (green). and
for NMNAT (red). NMNAT is highly enriched in the photoreceptor cell
body in the eye and in the cell bodies of different types of neurons in the
lamina cortex and medulla cortex, but is present at lower levels in lamina.
la, lamina; lc, lamina cortex; mc, medulla cortex; me, medulla.
(G–I) MARCM analysis of adult lamina. GFP marks the mutant patches.
Laminae are immunolabeled with nc82 to mark photoreceptors (blue)
and for NMNAT (red). NMNAT labeling appears as a punctate pattern
decorating nc82 labeling, suggesting that NMNAT is present in clusters
in photoreceptor terminals.
(J–L) Adult brain immunolabeled with TOTO3 to mark nuclei (blue), with
nc82 to mark active zones (green), and for NMNAT (red). NMNAT is
expressed at higher levels in neuronal nuclei (marked by TOTO3) in the
brain and lower levels in the neuropil (marked by nc82). AL, antenna
lobe; MB, mushroom body.
Scale bars indicate 5 lm.
DOI: 10.1371/journal.pbio.0040416.g003
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NMNAT Maintains Neuronal Inegritypredicted genes in the mouse, but only Nmnat1 has been
characterized, mostly as part of the chimeric Wld
s protein.
Drosophila CG13645 is equally homologous to mouse and
human NMNAT1, 2, or 3 with approximately 45% identity
over the entire protein (Figure 2C). Since it is the only
NMNAT found in the ﬂy genome, we named it nmnat.A s
shown in Figure 2D, the predicted enzyme activity center
consists of an N-terminal catalytic domain and two substrate-
binding motifs. The sequence conservation between Droso-
phila NMNAT and other NMNATs within the activity center is
greater than 95%. To test whether nmnat encodes an active
NMN adenylyltransferase, we produced recombinant protein
and measured the enzyme activity using a continuous
coupling assay. The ﬂy protein has similar NMNAT activity
as the human NMNAT3 control. When a single amino acid in
the catalytic motif (‘‘H30A’’), or two amino acids in the
substrate binding motifs are mutated (W98G/R224A and
‘‘WR’’), the enzymatic activity is reduced to approximately
1% or less of the wild-type protein (Figure 2E). These data
indicate that nmnat encodes an active NMNAT with a similar
enzyme activity center composition as its vertebrate homo-
logs.
Both mouse and human NMNAT1 have been shown to
primarily localize to nuclei [17,32], whereas human NMNAT3
is present in the cytoplasm and mitochondria [35]. To
characterize the localization of the NMNAT protein, we
generated a polyclonal antibody against the full-length
protein. The speciﬁcity of the antibody was veriﬁed in mosaic
clones of D4790–1 or D4790–2 in eye discs (Figure S2). Mutant
patches of nmnat
1 or nmnat
2 also lack antibody staining at a
similar level as mutant patches of D4790–1 or D4790–2
(Figure S2), suggesting nonsense-mediated decay of the
transcripts in both EMS alleles, further supporting the
genetic data, which indicate that both EMS alleles are null
alleles or severe hypomorphs. The antibody enabled us to
examine the protein expression pattern by immunohisto-
chemistry in wild-type animals (Figure 3). In third instar
larvae, NMNAT is abundantly expressed in neuronal nuclei in
the brain and ventral nerve cord (unpublished data) and in
muscle cell nuclei (Figure 3A–3C). Relatively low levels of
Figure 4. Loss of nmnat Causes Severe and Progressive Age-Dependent Degeneration
(A–E) Retinal sections of control (iso), nmnat mutant eyes of different ages, and a trp
P365 mutant eye. Reduced rhabdomeres and vacuoles are seen in
Pþ96%, and both phenotypes become more severe with age. The nmnat mutant retina has a more severe phenotype than trp
P365 in age-matched
animals.
(F–J) TEM micrographs of lamina cartridges. Demarcating glia are colored blue and photoreceptor terminals green to accentuate the structures. In
the mutant lamina, the number of structurally intact photoreceptor terminals gradually reduces with age. The trp
P365 mutant lamina has a rather
organized cartridge structure. The red boxes in (F–J) indicate the regions shown in (K–O), respectively. Scale bar in (F) for (F–J) indicates 1 lm.
(K–O) Individual synapses boxed in (F–J). In mutant photoreceptors, active zone structures gradually disintegrate with age (arrows); however, the
morphology of the T-bars in trp
P365 is well preserved. Scale bar in (K) for (K)–(O) indicates 200 nm.
(P) Quantification of the number of terminals per cartridge of control (iso) or mutant laminae at different ages. The photoreceptor terminals are
recognized by the presence of capitate projections. In mutant laminae, the number of structurally intact photoreceptor terminals decrease with age,
and dark rearing can delay the decline. The number of cartridges quantified is indicated above each graph.
(Q) ERG recordings of control (iso) and mutant photoreceptors at 1 d and 8 d of age. At 8 d, mutant photoreceptors have minimal responses to light.
DOI: 10.1371/journal.pbio.0040416.g004
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NMNAT Maintains Neuronal Inegrityprotein are present at the neuromuscular junction where the
protein partially co-localizes with the active zone marker
monoclonal antibody (mAb) nc82 (Figure 3A–3C). In the
pupal optic lobe, NMNAT is expressed in the cell bodies of
photoreceptors and numerous optic lobe neurons (Figure
3D–3F). In the adult optic lobe, NMNAT is expressed in the
cell bodies of photoreceptors as well as in the terminals of the
lamina neuropil. At synapses, NMNAT labeling appears to be
punctate where it co-localizes with the active zone marker
nc82, suggesting that NMNAT is present in the photoreceptor
terminals (Figure 3G–3I). In the adult central brain, the
expression persists with high levels in neuronal nuclei and,
albeit at substantially lower levels, in synaptic neuropils
(Figure 3J–3L). In summary, NMNAT is enriched in the
nervous system, both in the neuronal nuclei and the nerve
terminals, as well as in the muscle cell nuclei. However,
expression of NMNAT in the nervous system using the pan-
neuronal driver elav-GAL4, in contrast to ubiquitous actin-
GAL4–driven expression, cannot rescue the lethality associ-
ated with the loss of NMNAT protein (Table S1), indicating
that NMNAT function is not conﬁned to the nervous system.
Loss of nmnat Causes Severe Early-Onset Neuronal
Degeneration
The reduced capability of nmnat mutant photoreceptors to
respond to light, as revealed by ERG, can have several
underlying causes: a defect in the phototransduction cascade,
or a defect of the structural components of the photo-
transduction machinery, e.g., in rhabdomeres, the membrane
stack in which the phototransduction components reside. We
therefore examined the morphology of mutant retinae. The
regular organization pattern of ommatidia can be visualized
in a retina cross-section (Figure 4A). As shown in Figure 4, in
2-d-old mutant retinae, rhabdomeres are reduced in size, and
large vacuoles are abundant in individual ommatidia. This
phenotype becomes more severe with age, as in 28-d-old
retinae, rhabdomeres are barely recognizable (Figure 4D).
Since the exterior morphology of these eyes look normal, we
examined the onset of the phenotype and sectioned pupal
retinae. At 96 h after puparium formation (APF; Pþ96%), just
prior to eclosion, some defects are already prominent, and
the size of rhabdomeres is reduced when compared to those
of wild type. However, the phenotype is clearly less severe
than in older retinae (Figure 4B versus 4D). TEM of
photoreceptor terminals in the lamina (R1–R6 terminals)
also reveals defects that follow a similar degenerative proﬁle
as that observed at the cell body. At Pþ96%, synaptic
modules, or cartridges, formed by R1–R6 in the lamina are
well organized with six photoreceptor terminals per car-
tridge, and the active zone structures are clearly discernible,
indicating that the development of the photoreceptor
terminals is mostly normal (Figure 4G and 4L). As the
mutant photoreceptors age, the number of recognizable
terminals per cartridge declines (quantiﬁed in Figure 4P),
and the active zone structure becomes smaller and amor-
phous (Figure 4H, 4I, 4M, and 4N). This phenotype correlates
with the progression of the cell body defects. The magnitude
of the depolarization and the on/off transients in ERG
recordings also decline with age. At 8 d, the ERG response is
barely present (Figure 4Q). A comparison with two of the
most severe Drosophila retinal degeneration mutants, rdgA
(retinal degeneration A) and trp
P365 (transient receptor potential)
[36–39], reveals that nmnat mutant retinae have similar but
more severe defects (Figure 4C and 4E, and unpublished
data). Interestingly, the photoreceptor terminals of both rdgA
and trp
P365 show a rather normal morphology, with correctly
organized cartridges containing intact T-bars (Figure 4E, 4J,
and 4O, and unpublished data), suggesting that degeneration
in these mutants is more restricted to the retina. In summary,
in nmnat mutant photoreceptors numerous cellular struc-
tures are disrupted throughout the entire neuron, from the
rhabdomere to the presynaptic terminal, and the phenotype
becomes progressively more severe with age.
To assess whether the development of the photoreceptors
and accessory cells are affected in nmnat mutant eyes, we
compared the morphology of mutant photoreceptors with
neighboring wild-type cells by immunoﬂuorescence labeling
with several markers. We immunolabeled with antibodies
against Actin to reveal rhabdomere structures, Armadillo to
reveal the presence and morphology of adherence junctions
Figure 5. nmnat Mutant Photoreceptors Develop Normally
MARCM analysis of pupal eye disc at 30 h after puparium formation ( Pþ30%) (A–D) and 50 h after puparium formation Pþ50% (E–H). GFP marks the
mutant patch in (D) and (H). Anti-Actin antibody labels the rhabdomere structure in (B) and (F). Anti-Armadillo antibody labeling (Arm) marks the
adherence junction in (C). Anti-NMNAT antibody shows labeling in wild-type cell bodies, but is dramatically reduced or absent in the mutant patch (G).
In both developmental stages, there are no detectable structural differences between wild-type and mutant patches.
DOI: 10.1371/journal.pbio.0040416.g005
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NMNAT Maintains Neuronal Inegritybetween photoreceptors, and NMNAT to identify mutant
cells. Photoreceptor subtype speciﬁcation and differentiation
are mostly completed by 50% of pupal development [40]. We
therefore stained pupal eyes at both 30% and 50% of
development and observed no morphological difference
between mutant and wild-type tissue (Figure 5), suggesting
that mutant photoreceptors develop normally. In addition,
TEM at Pþ96% reveals normal synapse formation by
qualitative as well by quantitative criteria (Figure 4G and
4L). We conclude that nmnat is not required for photo-
receptor differentiation and development, but rather for the
maintenance and integrity of mature neurons. In addition,
loss of nmnat causes a general and severe neurodegenerative
phenotype that spans all structures of the neuron including
rhabdomeres, cell bodies, axons, and active zones. Hence,
nmnat is required for neuronal integrity after differentiation.
Neurodegeneration Caused by Loss of nmnat Is Enhanced
by Activity
In an attempt to dissect the mechanisms underlying the
neurodegeneration of mutant photoreceptors, we ﬁrst tested
whether the degeneration is light dependent, because a
common cause for retinal degeneration is light stimulation
[41,42]. Indeed, when ﬂies with nmnat mutant photoreceptors
are raised in the dark and sectioned at 1 d of age for TEM,
they exhibit an overall normal organization of ommatidia
similar to wild-type controls (Figure 6D and 6E), a phenotype
that is signiﬁcantly less severe than in ﬂies kept on a 12-h
light/dark cycle (Figure 6B). In addition, the morphology of
nmnat mutant photoreceptor terminals in dark-reared ﬂies is
comparable to those of wild-type ﬂies (Figure 6G and 6H),
and is signiﬁcantly less severe than in ﬂies kept on a 12-h
light/dark cycle (Figure 1H and 1I). Notably, ﬂies kept in the
dark for 10 d exhibit a phenotype that is much less severe
than in similarly aged animals kept in a light/dark cycle
(Figure 6C). However, signs of degeneration, such as smaller
rhabdomeres, the presence of vacuoles in the cell body, and
ultrastructural defects in the photoreceptor terminals, are
obvious (Figure 6F and 6I). These data show that light
dramatically enhances the degenerative process in nmnat
mutant cells and indicate that the normal function of
NMNAT is to provide a potent protection against light-
induced degeneration in adults.
To further establish whether neuronal activity is mediating
the degenerative process, we tested whether mutants that
impair the phototransduction cascade partially protect
photoreceptors from neurodegeneration induced by the loss
of nmnat. norpA (no receptor potential A) encodes a phospholi-
pase C, which is required for phototransduction [43]. In
norpA
P24 mutants, phototransduction is blocked [43–45]. We
ﬁnd that in photoreceptors mutant for both norpA
P24 and
nmnat, neurodegeneration is partially suppressed (Figure 7B
and 7C). The overall ommatidial structure is better organized,
the vacuoles in the ommatidia are smaller, and the number of
rhabdomeres is greater than in nmnat mutants (Figure 7E).
These observations further indicate that photoreceptor
degeneration caused by loss of nmnat can be attenuated by
reducing neuronal activity.
Next, we tested whether neural degeneration in nmnat
mutant photoreceptors is related to apoptosis. If so, neuronal
degeneration should be suppressed by proteins that inhibit
apoptosis. We therefore expressed the apoptosis-inhibiting
factor P35 [46] in nmnat mutant photoreceptors. We ﬁnd that
P35 expression does not suppress any phenotype associated
with the loss of nmnat (Figures 7C–7E), suggesting that nmnat-
dependent degeneration is independent of the P35-mediated
apoptotic pathway.
Enzymatically Inactive NMNAT Rescues
Neurodegeneration
In an in vitro culture system, NAD synthesis is required for
the Wld
s protein to delay axon degeneration [19], and
exogenous local application of NAD can prevent axon
degeneration [21]. On the other hand, NAD levels were
shown to be unchanged in Wld
s axons that show delayed
Figure 6. Light Enhances Neurodegeneration in nmnat Mutant Photo-
receptors
(A–C) TEM micrographs of control (iso) or nmnat mutant ommatidia at 1
d or 10 d of age kept in 12-hr light/dark cycle (12hr D/12hr L). Note the
dramatic reduction of rhabodmere size at 1 d of age (B). This phenotype
becomes more severe by day 10 (C). Genotypes and ages are marked on
the top of each column.
(D–F) TEM micrographs of control or nmnat mutant ommatidia at 1 d or
10 d of age reared in constant darkness. Note the dramatic improvement
at day 1 ([B] versus [E]) and day 10 ([C] versus [F]).
(G–I) TEM micrographs of cartridges containing control and nmnat
mutant terminals at 1 d or 10 d of age reared in constant darkness. At 1 d
of age, the mutant photoreceptor terminals are well organized,
compared to the mutant photoreceptors of the same-aged flies raised
in regular light/dark cycle (Figure 1H and 1I). Quantification of the
number of terminals per cartridge is shown in Figure 4P. Dark rearing
does not block synaptic degeneration, as at 10 d of age, the number of
structurally intact photoreceptor terminals is reduced (I). Demarcating
glia are colored blue and photoreceptor terminals green to emphasize
the structures. Scale bars in (A) for (A–F) and in (G) for (G–I) indicate 1
lm.
DOI: 10.1371/journal.pbio.0040416.g006
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NMNAT Maintains Neuronal Inegritydegeneration [12]. If the protective effect of Wld
s and
NMNAT occurs through enzymatic activity and hence NAD
production, enzymatically inactive NMNAT should not rescue
degeneration. To test this hypothesis, we generated trans-
genic ﬂies that encode two different versions of enzymatically
inactive NMNAT, nmnat-H30A, in which the catalytic center is
mutated, and nmnat-WR, in which two key residues required
for substrate binding are mutated. Both proteins have
approximately 1% or less enzymatic activity of the wild-type
protein in vitro (Figure 2D and 2E). To our surprise, when the
inactive enzymes are expressed in nmnat mutant photo-
receptors at similar levels as wild-type protein (Figure S3),
synaptic structures are fully rescued and rhabdomere size are
rescued to 80%–85% of wild type (Figure 8 and Table S1).
Importantly, the magnitude of the ERG depolarization in
these rescued photoreceptors is more than 75% of wild type,
comparable to the rescue with human NMNAT3 gene
(HsNmnat3) (Figure 8 and Table S1), indicating that the
inactive enzyme can rescue the neuronal degeneration caused
by nmnat loss of function.
Interestingly, when we express wild-type NMNAT or
enzymatically inactive NMNAT in the entire mutant animal
using a ubiquitous driver (actin-GAL4), only the wild-type
NMNAT is able to rescue the mutant animal to adulthood
(Table S1). These data strongly suggest that the mutant
enzymes lack activity in vivo and in vitro, and that NMNAT is
a multifunctional protein that has two independent roles:
NAD synthesis, which is required for viability, and a NAD-
independent function that protects against neuronal activity-
induced degeneration in mature photoreceptors.
Overexpression of nmnat Protects against Excessive
Activity-Induced Neurodegeneration
Delayed Wallerian degeneration in Wld
s mice demonstrates
the protective effect of the chimeric gene Ube4b/Nmnat [12].
To investigate if overexpression of Drosophila nmnat has
protective effects, we tested enzymatically active and inactive
forms in hyperactivity-induced neurodegeneration. First, we
overexpressed nmnat in the retinal degeneration mutants,
rdgA and trp
P365 [36,39,47]. It has been shown that in both rdgA
Figure 7. Loss of NMNAT-Induced Degeneration Can Be Attenuated by Blocking Phototransduction and Is Independent of Apoptosis
(A) and (B) Ommatidial morphology of 1-d-old norpA mutant (A) or norp; nmnat double mutant (B) retina. norpA mutant retina appears normal at this
age. norpA; nmnat double mutant retina has greatly improved rhabdomere structure when compared to nmnat single mutant (C).
(C) and (D) Ommatidial morphology of nmnat mutant retina (C) or mutant retina overexpressing P35 (D). There are no detectable differences between
(C) and (D), suggesting that P35 overexpression does not rescue the degeneration induced by loss of nmnat.
(E) Quantification of the number of rhabdomeres and vacuole size for each genotype. Blue columns are the number of rhabdomeres per ommatidium,
and the red columns are the vacuole size per 10 lm
2 of ommatidia. Six animals per genotype and 400 lm
2 of ommatidia per animal were quantified.
Double asterisks (**) indicate p , 0.005; and triple asterisks (***) indicate p , 0.0005 (Student t-test).
DOI: 10.1371/journal.pbio.0040416.g007
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P365 mutant photoreceptors, retinal degeneration is
caused by constitutive activation of Trp channels
[38,39,48,49]. The primary phenotypes of both mutants are
loss of rhabdomeres, disorganization of ommatidia, and
vacuolarization throughout the retina and photoreceptors
(Figures 9A and 9E). Overexpression of wild-type nmnat or
mutant nmnat-WR transgenes partially restores the ommati-
dial organization (Figure 9A versus 9B and 9C; Figure 9E
versus 9F and 9G), signiﬁcantly reduces vacuole size in rdgA
(Figure 9D), and causes the presence of a higher number of
rhabdomeres per ommatidium than in controls that do not
overexpress nmnat (Figure 9D and 9H).
In a second paradigm, we induced photoreceptor degen-
eration by exposing wild-type ﬂies to constant intense light, a
strong environmental insult that induces neurodegeneration
[50–52]. Thirty days of constant, intense light exposure
induces numerous small, as well as very large, vacuoles in
wild-type retinae, and a reduced number of rhabdomeres
(Figure 9J). In contrast, retinae overexpressing wild-type
nmnat or nmnat-WR have signiﬁcantly reduced size of vacuoles
and a higher number of rhabdomeres per ommatidium
(Figure 9K, 9L, and 9M). These data show that overexpression
of nmnat, either wild type or enzymatically inactive, can
protect against severe retinal degeneration caused by
excessive neuronal activity.
Discussion
Here we report the identiﬁcation and characterization of
Drosophila nmnat and the ﬁrst mutant analysis of nmnat in any
multicellular organism. Our data reveal an essential neuronal
protective function for nmnat, which is required for neurons
to sustain normal neuronal activity. This function is inde-
pendent of its enzymatic activity and can be exploited to
protect neurons against activity-induced neurodegeneration.
Maintaining Neuronal Integrity
Our mutant analyses provide the ﬁrst evidence that
neuroprotection is a normal function of the endogenous
protein, in contrast to previous overexpression reports
[16,18]. Several lines of evidence support a role of NMNAT
in protecting adult neurons against activity-induced degen-
eration. First, in the absence of nmnat, darkness delays the
degeneration process of photoreceptors signiﬁcantly. Second,
mutations that impair components of the phototransduction
cascade partially suppress the degeneration caused by loss of
nmnat. Third, mutants in which photoreceptors degenerate
due to constitutive phototransduction (rdgA and trp
P365)
[38,39,48], are partially protected by overexpression of nmnat.
Finally, overexpression of nmnat in ﬂies that are exposed to
intense light potently protects against neuronal degenera-
tion. These observations provide evidence that NMNAT
functions to maintain the integrity of mature neurons by
protecting them from use-dependent degeneration. This
protection is likely to be independent of the NAD synthesis
activity of NMNAT, because enzymatically inactive NMNAT
proteins protect as effectively as the wild-type protein.
Hence, our data indicate that a normal neuronal function
of nmnat is to protect from activity-induced neurodegenera-
tion. It is possible that the endogenous level of NMNAT is
only sufﬁcient to cope with the deterioration caused by
normal levels of neuronal activity, but not enough for injury,
Figure 8. Enzymatically Inactive NMNAT Can Rescue the Neurodegeneration Phenotype Caused by Loss of nmnat
(A–F) ERG recordings of mutant photoreceptors overexpressing human NMNAT3 (A), or inactive Drosophila NMNAT forms H30A (C) or WR (E) in nmnat
mutant photoreceptors. The genotypes are marked on top of each column. Note that the magnitudes of both depolarization and on/off transients are
partially restored. (B), (D), and (F) Retinal structures are partially restored in each genotype.
(G–I) TEM micrographs of lamina cartridges. Photoreceptor terminals are well organized in cartridges, similar to wild type. Demarcating glia are colored
blue and photoreceptor terminals are colored in green to identify the structures. The red boxes in (G) indicate the regions shown in (J) and (K); the
boxes in (H) indicate the regions shown in (L) and (M); and the box in (I) indicates the region shown in (N). Scale bar in (G) for (G–I) indicates 1 lm.
(J–N) Individual terminals boxed in (G–I). All active zones have defined platform (arrowheads) and pedestal structures. Scale bar in (J) for (J–N) indicates
200 nm.
DOI: 10.1371/journal.pbio.0040416.g008
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propose that in the absence of NMNAT, the deterioration
caused by normal activity cannot be overcome and is enough
to induce degeneration.
Is NAD Required for the Protective Effect?
The normal development of nmnat mutant eyes suggests
that nmnat is not required for neuronal speciﬁcation, differ-
entiation, axon pathﬁnding, or synapse formation. Given that
NAD is required for cell survival, it is likely that NAD
production by other enzymes compensates for the NAD
synthesis function of nmnat, because NMNAT catalyzes one of
the salvage pathways of NAD synthesis [53]. The de novo and
alternative synthesis pathways are catalyzed by enzymes
including NAase (nicotinamidase), NaPRTase (nicotinamide
phosphoribosyltransferase), and NADS (NAD synthase), and
there are predicted genes with each of these enzymatic
activities in the ﬂy genome [53] (see Figure S4).
It has been shown in an in vitro culture system that NAD
can protect injured axons from degeneration [19,21]. How-
ever, this protective effect is not speciﬁc to NAD, because
pyruvate or EGTA have similar effects in the same studies
[21]. It is equally possible that exogenously applied NAD can
‘‘free up’’ NMNAT from its NAD synthesis function and allow
Figure 9. Overexpression of Enzymatically Active or Inactive NMNAT Can Rescue the Neurodegeneration Phenotype Caused by rdgA, trp
P365, and
Constant Light Exposure
(A–D) Ommatidial morphology of rdgA mutant retinae (A) expressing wild-type NMNAT (B) or enzymatically inactive NMNAT (C) at 2 d of age. The
quantification of the number of rhabdomeres per ommatidium (blue columns) and the size of vacuoles per surface area (red columns) are displayed (D).
The number of rhabdomeres per ommatidium is significantly rescued by expression of wild-type or enzymatically inactive NMNAT. The vacuole size is
significantly reduced with the expression of inactive NMNAT but not wild-type NMNAT.
(E–H) Ommatidial morphology of trp
P365 mutant retinae (E) expressing wild-type NMNAT (F) or enzymatically inactive NMNAT (G) at 2 d of age. The
quantification of the number of rhabdomeres per ommatidium (blue columns) and the size of vacuoles per surface area (red columns) are displayed in
(H). The number of rhabdomeres per ommatidium is significantly rescued by expressing enzymatically active or inactive NMNAT, although the vacuole
size remains unchanged.
(I–M) Ommatidial morphology of 30-d-old wild-type flies either kept under ambient light in a 12-h light/dark cycle (I), or under constant intense light
(2.2 kLux) (J–L). Overexpression of wild-type NMNAT (K) and the inactive protein NMNAT-WR (L) significantly protect ommatidial morphology compared
to wild type (J). Quantification (M) shows an increased number of rhabdomeres per ommatidium (blue columns) and a reduction in vacuole size (red
columns). Five animals per genotype and 400 lm
2 of ommatidia per animal were quantified. A single asterisk (*) indicates p , 0.05; double asterisks (**)
indicate p , 0.005; and triple asterisks (***) indicate p , 0.0005 (Student t-test).
DOI: 10.1371/journal.pbio.0040416.g009
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delaying degeneration. More puzzlingly, Araki et al. [19]
showed that enzymatically inactive NMNAT bearing a mutant
substrate binding motif (W170A) cannot delay axon degen-
eration. Mutation of the equivalent substrate binding motif of
the Drosophila homolog in our assay reduced its activity to
10.8% of wild type (Figure 2E; W98G). Furthermore,
mutations of both substrate binding motifs (Figure 2E; WR)
reduce the activity to 0.9% of wild type, which is less than 1/10
that of the single motif mutant, but when expressed in the ﬂy,
both mutant enzymes provide an equal level of protection
against neurodegeneration. Whether this discrepancy is due
to differences in expression levels, or differences between in
vitro and in vivo systems, remains to be resolved.
If the neuroprotective effect of MNNAT/Wld
s is independ-
ent from its NAD synthesis activity, what might be the
underlying molecular mechanism? Studies of several neuro-
degenerative diseases suggest that ubiquitin-mediated pro-
teasome degradation and chaperone-mediated protein
folding may play an important role in these degenerative
processes [3,54–61]. Studies of a Drosophila model of Wallerian
degeneration also indicate a protective effect by inhibiting
ubiquitination [14]. Interestingly, the N-terminal part of the
Wld
s fusion protein N70-Ube4b is able to bind an important
proteasomal chaperone (VCP) in vitro, and relocates it to the
nucleus in cultured cells, suggesting a potential role for
chaperones [20].
In conclusion, our genetic and functional analyses present
evidence that, in addition to its NAD synthesis activity, a
neuronal function of nmnat is to maintain neuronal integrity
under normal conditions, and neuronal activity potentiates
the degeneration that occurs when Nmnat is lost. By
extension, more NMNAT protects neurons from neuronal
activity induced degeneration. This activity, which is enzyme
independent, indicates that the protein has two independent
functions: NAD synthesis and maintenance of neuronal
integrity.
Materials and Methods
Drosophila strains and conditions of culture. Flies were reared at
room temperature in ambient light under a normal 12-h light/dark
cycle. For dark-rearing experiments, ﬂies were kept in complete
darkness from the ﬁrst instar larval stage onwards. For pupal staging
experiments, ﬂies were reared at 25 8C (100% pupal development
corresponds to 103 h).
Antibody production. The full-length cDNA was cloned into the
pET28a (Invitrogen, Carlsbad, California, United States) vector for
protein expression (gift of S. Wu). The cDNA fragment was cloned
into EcoRI and NotI restriction sites using PCR primers that
introduced those sites into the cDNA fragment as described for the
cDNA rescue construct. Guinea pig antibodies against this domain
were raised by Cocalico Biologicals (Reamstown, Pennsylvania,
United States) using the puriﬁed recombinant protein. The poly-
clonal antisera were puriﬁed using the Protein A IgG Puriﬁcation kit
(Pierce Biotechnology, Rockford, Illinois, United States). Antibody
speciﬁcity was conﬁrmed by lack of staining in mutant clonal tissue
incubated with anti-NMNAT (Figures 4 and S2).
Drosophila strains, mutagenesis, and screen. yw ; ;
Pfry
þt7.2¼neoFRTg82B isogenized ﬂies were used for mutagenesis and
as control animals. Mutagenesis, ERGs, and phototaxis assays were
performed as described [24]. The eyFLP screen of chromosome arm
3R is described in Mehta et al. [22].
Construction of rescue constructs and transgenic ﬂies. Our
genomic rescue construct consists of the nmnat genomic locus ﬂanked
by 0.4 kb of upstream genomic sequence and 0.5 kb of downstream
sequence. The following primers were used to amplify this sequence
from a clone in P1 phage library containing the CG13645 locus:
primer1 59-accgaattcgagcaggagcccgccacac-39 and primer 2 59-ataa-
gaatgcggccgcgtggactcttccaagggaagcaagc-39. Primer 1 contains an
EcoRI site and primer 2 contains a NotI site to facilitate cloning.
After sequence veriﬁcation, the genomic fragment was cloned into
the vector pPfCaSpeR-4g, and transgenic ﬂies were generated. For
cDNA rescue experiments, we cloned the full coding sequence of
cDNA clone AT23490 (Drosophila Gene Collection, http://www.
fruitﬂy.org/DGC/index.html) into pPfUASTg and pPfUAST-HAg (gift
from B. Tavsanli), and generated several transgenic lines. The
following primers were used to introduce EcoRI and NotI sites at
the ends of the nmnat coding sequence for ease of cloning: 59–
CCGGAATTCATGTCAGCATTCATCGAGGAAAC-39 and 59–
TTTTCCTTTTGCGGCCGCAGAGTCGCATTCGGTCGGAGCCG-39.
Site-directed mutagenesis and generation of recombinant protein.
Inactive enzyme was created by site-directed mutagenesis of full-
length nmnat cDNA in pET28a vector using QuikChange Site-
Directed Mutagenesis Kit (Stratagene, La Jolla, California, United
States). The H30A, W98G, and R224A mutations were made by one
round of mutagenesis, and the WR double mutation was made by
sequential mutagenesis. The recombinant protein was generated, and
the protein concentration was measured by Bradford assay (BioRad,
Hercules, California, United States). The mutant cDNAs nmnat-H30A
and nmnat-WR were subcloned into pPfUASTg, and transgenic lines
were generated.
NMNAT activity assay. Activity of NMNAT (synthesis of NAD) was
measured in a continuous coupled enzyme assay by monitoring the
increase in absorbance at 340 nm caused by the reduction of NAD to
NADH as described [62]. Brieﬂy, the reaction was performed at 37 8C
in 16 nM semicarbacide-HCl, 0.625% (v/v) ethanol, 30 nM HEPES
buffer (pH 7.4), 12.25 nM MgCl2, 1.17 mM ATP, 15 U yeast alcohol
dehydrogenase (Sigma, St. Louis, Missouri, United States), puriﬁed
recombinant NMNAT, and was initiated by adding NMN to a ﬁnal
concentration of 0.625 mM. The activity is determined from the
linear progression curve using the following formula:
Eunit=mg ¼
DA340nm=min3Vreaction
Cob  NADH 3Venzyme 3½enzyme 
ð1Þ
where Cob-NADH, the extinction coefﬁcient of b-NADH at 340 nm, is
6.22.
Retina sections and TEM. Flies of different ages were dissected and
ﬁxed at 4 8C in 2% paraformaldehyde; 2% glutaraldehyde; 0.1 M
sodium cacodylate; 0.005% CaCl2 (pH 7.2), and postﬁxed in 2% OsO4.
The 200 nm–thick sections of retina were stained with 1% toludine
blue O, 1% sodium tetraborate (Electron Microscopy Sciences,
Hatﬁeld, Pennsylvania, United States). The 50-nm thin sections were
stained with 4% uranyl acetate and 2.5% lead nitrate. Synaptic
features of laminae were scored double-blind by several observers.
For photoreceptor terminal quantiﬁcation, photoreceptor terminals
were identiﬁed by the presence of capitate projections [27]. In all
electron microscopy analyses, we analyzed samples from at least four
different animals per genotype.
Immunocytochemistry. Eye discs, third instar larval ﬁllets, and
larval, pupal, and adult brains were ﬁxed in phosphate buffered saline
(PBS) with 3.5% formaldehyde for 15 min and washed in phosphate
buffered saline with 0.4% Triton X-100, or with 0.2% Tween 20 for
larval neuromuscular junction preparations. Antibody dilutions used:
anti-NMNAT 1:1,000; anti-Armadillo 1:200; mAb nc82 1:100; anti-
Actin mAb C4 1:200 (ICN Biomedicals, Costa Mesa, California, United
States); and TOTO3 1:2,000 (Molecular Probes, Eugene, Oregon,
United States). Anti-HRP and secondary antibodies conjugated to
Cy3, Cy5, or Alexa 488 (Jackson ImmunoResearch, West Grove,
Pennsylvania, United States; and Molecular Probes) were used at
1:250. All antibody incubations were performed at 4 8C overnight in
the presence of 5% normal goat serum.
Image acquisition and processing. Images from ﬂuorescently
labeled specimens were taken on a Zeiss LSM510 confocal micro-
scope (Zeiss, Oberkochen, Germany) and processed using Amira 3.0
(TGS, San Diego, California, United States) and Adobe Photoshop 7.0
(Adobe Systems, San Jose, California, United States).
Mosaic analyses. We used the MARCM technique [63] to analyze
the localization of various proteins in nmnat mutant photoreceptor
cells compared to their wild-type neighbors. All eye discs and laminae
shown with 50% mutant photoreceptor terminals are from animals of
the following genotype: ywe y F L PG M R - l a c Z ;P fw
þ¼UAS-
mCD8::GFP.LgLL4 / GMR-GAL4; FRT82B nmnat/ FRT82B Pfw
þ¼tub-
GAL80g. The negatively marked mutant eye disc clones in Figure S2
are from animals of the following genotype: y w eyFLP GMR-lacZ;
FRT82B nmnat/ FRT82B Pfw
þmC¼Ubi-GFP.nlsg.
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Figure S1. Genomic and cDNA Rescue of the Neurodegeneration
Phenotypes Caused by Loss of nmnat
(A–F) ERG recordings of mutant photoreceptors (A), photoreceptors
expressing the CG13645 genomic DNA (C), or photoreceptors
expressing CG13645 cDNA driven by GMR-GAL4 in the nmnat
1
mutant background (E). Both genomic DNA and cDNA expression
rescue the magnitude of depolarization and on/off transients. The
genotypes are marked at the top of each column. (B), (D), and (F)
Retinal structures of each genotype. Both genomic DNA and cDNA
expression restore the ommatidial morphology.
(G–I) TEM micrographs of lamina cartridges of each genotype. Both
genomic DNA and cDNA expression restore the photoreceptor
terminal structure and organization. Demarcating glia are colored
blue and photoreceptor terminals green. Scale bar in (G) for (G–I)
indicates 1 lm.
(J–O) Individual terminals boxed in (G–I). The active zone structures
are well organized with deﬁned platform structures (arrowheads),
compared to the amorphous structures in the mutant terminals
(arrows in J and K). Scale bar in (J) for (J–N) indicates 200 nm.
Found at DOI: 10.1371/journal.pbio.0040416.sg001 (8.8 MB TIF).
Figure S2. Polyclonal Antibodies Speciﬁcally Recognize NMNAT
Protein
Mosaic analysis of third instar larval eye disc. Wild-type control (iso)
or D4790–1, D4790–2, nmnat
1, or nmnat
2 mutant clones are negatively
marked. GFP marks the wild-type patch. Eye discs are labeled with
NMNAT antibody and TOTO3 to reveal the nuclei. In D4790–1,
D4790–2, nmnat
1, or nmnat
2 mutant clones, NMNAT staining is
dramatically reduced. The level of reduction in staining in nmnat
1
or nmnat
2 clones is similar to the level in D4790–1 or D4790–2 clones,
suggesting that nmnat
1 and nmnat
2 are likely protein null alleles. Scale
bars indicate 5 lm.
Found at DOI: 10.1371/journal.pbio.0040416.sg002 (8.3 MB TIF).
Figure S3. NMNAT and NMNAT-WR Are Expressed at Similar Levels
Using the GMR-GAL4 Driver
Western blot of ﬂy heads showing the level of NMNAT or NMNAT-
WR overexpression driven by either GMR-GAL4 or elav-GAL4 in a
wild-type background. Endogenous NMNAT and overexpressed
NMNAT or NMNAT-WR show slightly different migration patterns,
in which endogenous protein is highest around 35 kDa (arrow head
1), and overexpressed NMNAT (arrowhead 3) at around 30 kDa and
NMNAT-WR (arrowhead 2) at 32 kDa. The difference in size is likely
due to post-translational modiﬁcation. The expression level of
NMNAT-WR is slightly lower than NMNAT when driven with elav-
GAL4. Blotting for Actin was used as a control for equal loading.
Found at DOI: 10.1371/journal.pbio.0040416.sg003 (1.3 MB TIF).
Figure S4. NAD Synthesis Pathway
NAD can be synthesized through the de novo pathway from L-
tryptophan, or two salvage pathways from either nicotinic acid (Na)
or nicotinamide (Nam). The ﬂy homologs identiﬁed based on
sequence homology are shown in red.
Found at DOI: 10.1371/journal.pbio.0040416.sg004 (2.6 MB TIF).
Table S1. Rescue Loss of nmnat Phenotypes with nmnat cDNA
Both the wild-type and the inactive enzymes can rescue the
morphological and physiological phenotypes of nmnat mutant photo-
receptors. However, only the wild-type NMNAT, but not the
enzymatically inactive NMNAT, can rescue the organismal lethality
caused by loss of nmnat.
Found at DOI: 10.1371/journal.pbio.0040416.st001 (33 KB DOC).
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